The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 01, 2006

Filed:

May. 23, 2001
Applicants:

Martial Ruat, Bourg la Reine, FR;

Robert Dodd, Paris, FR;

Hélène Véronique Faure, Gif-sur-Yvette, FR;

Philippe Marcel Dauban, Bures-sur-Yvette, FR;

Albane Kessler, Paris, FR;

Pierre Jean-paul Potier, Paris, FR;

Inventors:

Martial Ruat, Bourg la Reine, FR;

Robert Dodd, Paris, FR;

Hélène Véronique Faure, Gif-sur-Yvette, FR;

Philippe Marcel Dauban, Bures-sur-Yvette, FR;

Albane Kessler, Paris, FR;

Pierre Jean-Paul Potier, Paris, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/404 (2006.01); A61K 31/4045 (2006.01); C07D 209/04 (2006.01); C07D 209/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention concerns compounds of general formula (I) wherein: the group X represents a —NR4, —CH═N or —CHR5-NR4-group; the group Y represents an oxygen or sulphur atom or a NR, —CR5, —CHR5-, —CR5=CR6- or —CHR5-CHR6 group provided that when group X represents the —CH═N— or —CHR5-NR4-group, group Y represents an oxygen or a sulphur atom or a Nr, —CR5 or —CHR group; the group R represents a hydrogen atom or an alkyl, aryl or aralkyl group; the groups R1, R5 and R6, identical or different, represent each a hydrogen or halogen atom or an alkyl or alkoxy group; the group R2 represents a hydrogen atom or an alkyl group; the group R3 represents an aryl group; and the group R4 represents a hydrogen atom, an alkyl, aryl, aralkyl, alkylsulphonamide, arylsulphonamide or aralkylsulphonamide group; and their salt with a pharmaceutically acceptable acid, in the form of a racemic mixture and their optically pure isomer. The invention also concerns their preparation, pharmaceutical compositions containing them and their use as CaSR activity modulator and as medicine for preferably treating diseases or physiological disorders involving the intervention of CaSR activity modulation.


Find Patent Forward Citations

Loading…